Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akebia Therapeutics

2.62
+0.16006.50%
Post-market: 2.59-0.0299-1.14%19:58 EDT
Volume:10.59M
Turnover:28.68M
Market Cap:685.88M
PE:-7.96
High:2.90
Open:2.78
Low:2.53
Close:2.46
Loading ...
May 12, 2020

Major Issues Report

8-K - Current report
May 05, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 20, 2020

Major Issues Report

Current report, item 8.01
Apr 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Apr 08, 2020

Major Issues Report

Current report, item 1.01
Apr 07, 2020

Major Issues Report

Current report, item 5.02
Mar 12, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 18, 2020

Major Issues Report

Current report, item 8.01
Feb 13, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 24, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Nov 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 12, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01